News

Highest concavity time may be another important parameter in describing corneal biomechanics as well as a potential risk factor for glaucoma.

Fluidvision accommodating intraocular lens (PowerVision) provides 5 D of accommodation with impressive results.

Phakic IOL implantation is safe and efficacious for treating high myopia and other conditions not amenable to LASIK, with outcomes comparable to those of LASIK and PRK.

There are many differences between adults and children which should be kept in mind when recognizing and treating glaucoma.

The concept of vision à la carte allows all ophthalmic surgeons to design vision for each patient individually, using all of today’s technologies and techniques.

Physicians’ namesake discoveries of various ocular signs provide a historical perspective.

Getting staff behind the benefits of photochromic eyeglass lenses is one of many effective ways to boost sales in the optical dispensary.

Patients with glaucoma undergoing cataract surgery require consideration of a number of factors to ensure optimal outcomes postoperatively.

Alcon Laboratories has announced the global launch of its phacoemulsification technology platform, a vision system designed to provide surgeons with enhanced cataract removal capabilities.

Clarity Medical Systems Inc.’s compact wavefront sensor module has received a patent from the U.S. Patent and Trademark Office.

ThromboGenics NV has entered into a collaboration and license agreement with Bicycle Therapeutics to develop and commercialize drugs inhibiting a specific target for the treatment of diabetic macular edema (DME).

The use of modern surgical techniques with or without IOL implantation does not eliminate the development of glaucoma or suspected glaucoma, according to recent study results.

Rigel Pharmaceuticals Inc. has announced its plans to focus the company’s resources on the completion of three lead clinical programs, including dry eye.

Identifying hypopituitarism in children with optic nerve hypoplasia (ONH) is important because they are at risk of impaired growth, hypoglycemia, seizures, brain damage, and death, according to Paul H. Phillips, MD.

Clarity Medical Systems Inc. has received a patent on optimizing vision correction procedures from the U.S. Patent and Trademark Office.

Prevent Blindness America (PBA) has dedicated the month of September as Sports Eye Safety Awareness Month in order to educate the public on the best ways to keep eyes safe while partaking in sports activities.

Bernard Becker, MD, chairman of the ophthalmology department at the Washington University School of Medicine in St. Louis for 35 years, has died.

Regeneron Pharmaceuticals’ new treatment for visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO) has been approved by the European Commission.

A prospective study randomly assigned 64 patients with open-angle glaucoma to surgery with a miniature glaucoma shunt or standard trabeculectomy, both with mitomycin-C.

Latanoprostene bunod is a probable new drug for the treatment of glaucoma that seems to be well tolerated and potent in lowering IOP.

A new fixed-combination of brinzolamide-brimonidine is a safe and effective option for lowering IOP in patients who are not candidates for a beta-blocker.

There are several vital components surgeons need to take into consideration when treating children who have traumatic cataracts.

An investigational non-invasive imaging tool, phase-sensitive optical coherence tomography can be used to detect and measure movement of the trabecular meshwork in vivo.

In an analysis of almost 2,000 eyes treated with selective laser trabeculoplasty as primary therapy for glaucoma, mean IOP decreased 29% and the cumulative probability of success at 10 years was 90%.

Research shows circadian variations in IOP can be regulated by orexin-containing neurons located in the hypothalamus

In a comparison of two wavefront-guided excimer lasers, one platform provides better clinical results on some measures but cannot image certain eyes. The other system can image nearly all eyes, but has slightly less robust clinical results.